First Tracks Biotherapeutics Inc current ratio

The Current Ratio as of October 2026 (TTM) for First Tracks Biotherapeutics Inc (TRAX) is 14.28

According to First Tracks Biotherapeutics Inc’s latest financial reports and current stock price. The company's current Current Ratio is 14.28. This represents a change of 71.95% compared to the average of 8.30 of the last 4 quarters.

First Tracks Biotherapeutics Inc (TRAX) Historical Current Ratio (quarterly & annually)

How has TRAX Current Ratio performed in the past?

The mean historical Current Ratio of First Tracks Biotherapeutics Inc over the last ten years is 14.28. The current 14.28 Current Ratio has changed -0.01% with respect to the historical average. Over the past ten years (40 quarters), TRAX's Current Ratio was at its highest in in the June 2026 quarter at 14.28. The Current Ratio was at its lowest in in the March 2025 quarter at 0.

First Tracks Biotherapeutics Inc (TRAX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of First Tracks Biotherapeutics Inc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

First Tracks Biotherapeutics Inc (TRAX) Average Current Ratio

How has TRAX Current Ratio performed in the past?

The current Current Ratio of First Tracks Biotherapeutics Inc (TRAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

First Tracks Biotherapeutics Inc (TRAX) Current Ratio vs. Peers

How is TRAX’s Current Ratio compared to its peers?

First Tracks Biotherapeutics Inc’s Current Ratio is greater than AnaptysBio, Inc. (5.61), greater than Attovia Therapeutics, Inc. (9.39), greater than SAB Biotherapeutics, Inc. (9.22), greater than MoonLake Immunotherapeutics (12.56), greater than Aclaris Therapeutics, Inc. (3.46), greater than Odyssey Therapeutics, Inc. (11.36), greater than Immunovant, Inc. (7.27), greater than Immunic, Inc. (5.05), greater than Eledon Pharmaceuticals, Inc. (7.90), less than Climb Bio, Inc. (31.45),

Build a custom stock screener for First Tracks Biotherapeutics Inc (TRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like First Tracks Biotherapeutics Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

First Tracks Biotherapeutics Inc (TRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like First Tracks Biotherapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.